【合集】ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

2017-03-03

由于人口的老龄化,老年退行性瓣膜病越来越多。瓣膜病的根本治疗是手术修复或瓣膜置换。然而作为内科医生却常常有很多无奈或困惑。即如何选择手术时机,特别是对老年患者。是应该一旦发现病变、有手术指征者就要尽早手术,以保障生活质量,以免延误了手术时机?还是再等等看,或许老人免了一次手术的创伤还可以维持一定的生活质量很多年呢? 当前针对各种疾病,各种技术都有层出不穷的“指南”,“共识”用以规范,指导临床医生

中文标题:

【合集】ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

发布机构:

发布日期:

2017-03-03

简要介绍:

由于人口的老龄化,老年退行性瓣膜病越来越多。瓣膜病的根本治疗是手术修复或瓣膜置换。然而作为内科医生却常常有很多无奈或困惑。即如何选择手术时机,特别是对老年患者。是应该一旦发现病变、有手术指征者就要尽早手术,以保障生活质量,以免延误了手术时机?还是再等等看,或许老人免了一次手术的创伤还可以维持一定的生活质量很多年呢? 当前针对各种疾病,各种技术都有层出不穷的“指南”,“共识”用以规范,指导临床医生的实践,希望能够最好的指导医生为患者做出最适合的抉择。瓣膜病是否也有指南来帮助我们抉择呢?瓣膜病的指南比之其他疾病要少得多,更新的频率也要稀疏得多。下面小编为大家整理了中国专家对ASE及AHA/ACC的心脏瓣膜病相关指南的中文版翻译,以期为临床医生做出抉择时有所帮助。

 一、经导管主动脉瓣植入、二尖瓣修复和人工瓣膜瓣周漏封堵的开展显著扩大导管技术在瓣膜返流和狭窄治疗中的应用范围。超声心动图在确定适于接受这些介入治疗的患者和术中监测中都起到了至关重要的作用。而且它也是介入治疗术后随访最基本的手段。对接受经导管介入治疗患者的评估对于超声心动图提出了有异于自身瓣膜或者人工瓣膜病变患者常规评价的要求。 
  • EAE/ASE 超声心动图在心脏瓣膜病经导管介入治疗新技术中应用的建议
  • 二、本文详细介绍了超声心动图评价瓣膜狭窄的方法,包括数据采集、测量和评估瓣膜狭窄严重程度的具体细节。这些建议都是基于大量临床研究文献的总结,并得到专家小组的认同。 
  • 关于临床实践中应用超声心动图评估瓣膜狭窄的建议
  • 三、本文通过对科学文献的总结及国际专家小组达成的共识,就超声心动图以及多普勒技术评价人工瓣膜功能做一综述,作为评价人工瓣膜的指南。 
  • 关于超声心动图及多普勒超声评价人工瓣膜的建议
  • 四、本文详细回顾了超声心动图及多普勒技术在评估成人瓣膜反流的应用,依据科研文献及专家达成的共识提供了评估瓣膜反流严重程度的建议。  
  • 关于二维及多普勒超声心动图评估自体瓣膜反流程度的建议
  • 五、美国心脏协会和美国心脏病学会( AHA/ACC)发布的《2014 年心脏瓣膜病患者管理指南》,是自2008 年以来该指南的首次更新,内容囊括了各种类型的获得性成人瓣膜疾病,提供的建议涵盖了疾病分期、诊断、药物治疗及介入( 手术和微创) 治疗。与2008 年指南相比,该指南重要的更新内容之一是更加重视早期干预瓣膜病,降低了干预治疗的门槛,在某种情况下,即使在症状发展之前,一些患者仍可以接受干预治疗。 
  • 2014 年美国心脏瓣膜病指南解读
  • 六、2014年3 月3 日, 美国心脏协会和美国心脏病学会(AHA/ACC)发布了《2014 年心脏瓣膜病患者管理指南》,在该指南中AHA/ACC 首次对心脏瓣膜病的分期、诊断、治疗(包括药物、手术及介入治疗)及管理等给出指导,并更新部分推荐意见。在这里,我们对新指南几个要点解读的同时, 着重分析新指南对主动脉瓣膜病的处理。 
  • 主动脉瓣病变处理指南新解
  • 评论区 (5)
    #插入话题
    1. [GetPortalCommentsPageByObjectIdResponse(id=954662, encodeId=461d95466240, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:41 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300331, encodeId=954e30033184, content=Mark一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLoqL7ZUE5NyoMGjoVIoiaxHibtvZRiaExFV4Uq0x0xE7Ob4DCST1bCvfFgt5faJXxdclyOz0IDAR8SA/132, createdBy=9b892077876, createdName=doctff_40360985, createdTime=Tue Mar 27 23:47:52 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178715, encodeId=fdc31e8715fb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Tue Mar 07 07:54:12 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178664, encodeId=aff61e866484, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Mon Mar 06 08:49:41 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178628, encodeId=48da1e86283d, content=老年性瓣膜病可以用介入治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 05 17:06:40 CST 2017, time=2017-03-05, status=1, ipAttribution=)]
      2021-04-07 ms6000001015893838

      资料好好,但无法分享,遗憾!

      0

    2. [GetPortalCommentsPageByObjectIdResponse(id=954662, encodeId=461d95466240, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:41 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300331, encodeId=954e30033184, content=Mark一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLoqL7ZUE5NyoMGjoVIoiaxHibtvZRiaExFV4Uq0x0xE7Ob4DCST1bCvfFgt5faJXxdclyOz0IDAR8SA/132, createdBy=9b892077876, createdName=doctff_40360985, createdTime=Tue Mar 27 23:47:52 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178715, encodeId=fdc31e8715fb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Tue Mar 07 07:54:12 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178664, encodeId=aff61e866484, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Mon Mar 06 08:49:41 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178628, encodeId=48da1e86283d, content=老年性瓣膜病可以用介入治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 05 17:06:40 CST 2017, time=2017-03-05, status=1, ipAttribution=)]
      2018-03-27 doctff_40360985

      Mark一下

      0

    3. [GetPortalCommentsPageByObjectIdResponse(id=954662, encodeId=461d95466240, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:41 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300331, encodeId=954e30033184, content=Mark一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLoqL7ZUE5NyoMGjoVIoiaxHibtvZRiaExFV4Uq0x0xE7Ob4DCST1bCvfFgt5faJXxdclyOz0IDAR8SA/132, createdBy=9b892077876, createdName=doctff_40360985, createdTime=Tue Mar 27 23:47:52 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178715, encodeId=fdc31e8715fb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Tue Mar 07 07:54:12 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178664, encodeId=aff61e866484, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Mon Mar 06 08:49:41 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178628, encodeId=48da1e86283d, content=老年性瓣膜病可以用介入治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 05 17:06:40 CST 2017, time=2017-03-05, status=1, ipAttribution=)]
      2017-03-07 1771ae4158m

      学习一下

      0

    4. [GetPortalCommentsPageByObjectIdResponse(id=954662, encodeId=461d95466240, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:41 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300331, encodeId=954e30033184, content=Mark一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLoqL7ZUE5NyoMGjoVIoiaxHibtvZRiaExFV4Uq0x0xE7Ob4DCST1bCvfFgt5faJXxdclyOz0IDAR8SA/132, createdBy=9b892077876, createdName=doctff_40360985, createdTime=Tue Mar 27 23:47:52 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178715, encodeId=fdc31e8715fb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Tue Mar 07 07:54:12 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178664, encodeId=aff61e866484, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Mon Mar 06 08:49:41 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178628, encodeId=48da1e86283d, content=老年性瓣膜病可以用介入治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 05 17:06:40 CST 2017, time=2017-03-05, status=1, ipAttribution=)]
      2017-03-06 1771ae4158m

      学习一下

      0

    5. [GetPortalCommentsPageByObjectIdResponse(id=954662, encodeId=461d95466240, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 14:27:41 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=300331, encodeId=954e30033184, content=Mark一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLoqL7ZUE5NyoMGjoVIoiaxHibtvZRiaExFV4Uq0x0xE7Ob4DCST1bCvfFgt5faJXxdclyOz0IDAR8SA/132, createdBy=9b892077876, createdName=doctff_40360985, createdTime=Tue Mar 27 23:47:52 CST 2018, time=2018-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178715, encodeId=fdc31e8715fb, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Tue Mar 07 07:54:12 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178664, encodeId=aff61e866484, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/23/ac01daf0962458a9eb8c0b1e2f6ce5bc.jpg, createdBy=04b81710322, createdName=1771ae4158m, createdTime=Mon Mar 06 08:49:41 CST 2017, time=2017-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178628, encodeId=48da1e86283d, content=老年性瓣膜病可以用介入治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sun Mar 05 17:06:40 CST 2017, time=2017-03-05, status=1, ipAttribution=)]
      2017-03-05 有备才能无患

      老年性瓣膜病可以用介入治疗

      0